Effect of selenium‐free parenteral nutrition on serum selenium of neonates and infants maintained on long‐term parenteral nutrition

Authors:

Abstract
Background: The risk of selenium deficiency increases for infants receiving long‐term parenteral nutrition (PN). This study analyzed selenium deficiency in neonates and infants requiring long‐term PN and evaluated the effect of intravenous (IV) selenium provision.Methods: This study was a retrospective study of neonates and infants who were admitted to a neonatal intensive care unit from January 2010 to December 2019, received PN for ≥2 weeks, and had their serum selenium concentration measured. Patients were divided into two groups, depending on their serum selenium concentration, a deficient group (n = 55) and a nondeficient group (n = 47).Results: Of the study participants, 53.9% (55 of 102) were deficient in selenium. No difference in demographic and clinical characteristics existed except bronchopulmonary dysplasia. A subgroup analysis was performed for patients (n = 29). The average dose of IV selenium administered to patients was 2.7 ± 1.0 mcg/kg/day. The average initial serum selenium concentration was 36.5 ± 18.0 mcg/L, and the serum concentration significantly increased to 52.5 ± 19.1 mcg/L after IV selenium administration (P < .001). The correlation between the average IV selenium dose and the change in serum selenium concentrations was statistically significant (r = .423; P = .022).Conclusion: Selenium deficiency is common in neonates and infants receiving long‐term PN. Serum selenium concentration increased proportionally as the IV selenium dose increased. Therefore, it is recommended to supply a proper dose of IV selenium depending on the degree of selenium deficiency.

This publication has 39 references indexed in Scilit: